PharmaCyte Biotech, Inc. (PMCB) Form 8-K — Oct 16, 2026
PharmaCyte Biotech dismissed CBIZ CPAs as its independent auditor on October 14, 2026, effective that date. The company simultaneously engaged Grassi & Co. to audit fiscal year 2027 results and review interim financials beginning with the quarter ending October 31, 2026. CBIZ's reports for fiscal years ended April 30, 2026 and 2025 contained no adverse or qualified opinions, and the company reports no disagreements with the former auditor.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.